You are here

Research Projects

Depression and anxiety are common, debilitating and chronic mental health conditions which can be difficult to effectively treat. We aim here to...

Project Aims: Identify genetic markers that predict the risk of valproate-induced birth defects. It is recognised that women with epilepsy who...

Alzheimer's disease (AD) patients are 10 times more likely to develop epilepsy compared with age-matched controls. The treatment of recurrent...

Gliomas are the most common type of intrinsic brain tumour and a major cause of morbidity and mortality for those afflicted by these highly invasive...
Supervisor: Dr Mastura Monif

Magnetic Resonance Imaging (MRI) represents the gold standard for radiological diagnosis and monitoring of neurological diseases such as multiple...
Supervisor: Dr Scott Kolbe

Multiple sclerosis, an autoimmune, neurodegenerative condition, is the most common cause of non-traumatic neurological disability in young adults....
Supervisor: Dr Vilija Jokubaitis

Post-traumatic epilepsy (PTE) is a recurrent seizure disorder due to brain injury following physical trauma. PTE accounts for 20% of symptomatic...
Supervisor: Miss Rui Li

The glymphatic pathway has been proposed as a key contributor to the clearance of fluid and metabolic waste products, such as amyloid beta and tau,...

A biomarker is an objectively measured characteristic of a normal or pathologic biological process. The development of novel interventions to treat,...

Schizophrenia is a complex neuropsychiatric condition with a broad symptom profile, and current treatments are inadequate in many patients. In...

Introduction: ACTIVE-MS is a highly innovative patient participation study that will be conducted in 300 people with relapsing MS at risk of...

Multiple sclerosis, an autoimmune, neurodegenerative condition, is the most common cause of non-traumatic neurological disability in young adults....
Supervisor: Dr Vilija Jokubaitis

Genetic variants have been found to cause epilepsy as well as affect how people respond to treatment. Whole exome sequencing is a new method of...

Schizophrenia is a complex psychiatric condition, and existing medications are not satisfactory. In particular, cognitive symptoms of schizophrenia,...
Supervisor: Dr Matt Hudson

The application of whole genome sequencing (WGS) in the clinical care of patients with epilepsy is increasingly viable as the cost of these assays...

A common set of pathological processes contribute to most, if not all, neurodegenerative diseases. The processes include chronic activation of...
Supervisor: Dr Ian Harding

Friedreich ataxia (FRDA) and Spinocerebellar ataxia’s (SCA’s) are rare, genetic neurodegenerative diseases that are associated with profound and...
Supervisor: Dr Ian Harding

Approximately 150,000 people are currently living with focal epilepsy in Australia, and over one third have seizures which cannot be controlled with...
Supervisor: Dr Andrew Neal

Point-of-care (POC) testing is the testing at the site of patient care. It is done on patients conveniently and immediately allowing patients and...

Multiple sclerosis (MS), an autoimmune, neurodegenerative condition, that affects almost 26,000 Australians. It is characterised by inflammatory...
Supervisor: Dr Vilija Jokubaitis

Pages